Evidence map›Paper›PMID 42252125›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2026

Fate mapping reveals a prenatal-to-neonatal wave of ILC2s with a history of Cd3g expression.

Aneta Pankow, Xiao-Hong Sun

Abstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Aneta PankowArthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, United States.ORCID 0009-0008-6897-5935
Xiao-Hong SunArthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, United States.ORCID 0000-0003-0572-2662

Funding

γδTCR-dependent and independent differentiation of innate lymphoid cellsR01AI178947 · NIAID · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI SUN, XIAO-HONG · 2023 to 2024
$1.4M
Establishing a lineage tracing system for studying thymus-derived innate lymphoid cellsR03AI175661 · NIAID · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI SUN, XIAO-HONG · 2023 to 2024
$171k
NIAID NIH HHS R01 AI178947NIAID NIH HHS R03 AI175661
6 · The paper itself

Abstract

Group 2 innate lymphoid cells (ILC2s) are thought to develop in the bone marrow and fetal liver. However, increasing evidence supports the presence of thymic ILC2s in mice and humans. In this study, we introduce a novel fate-mapping mouse model designed to track thymic ILC2s in peripheral tissues. Thymic ILC2s are labeled by ZsGreen, whose expression is induced by Cd3giCre. While they are present in the thymus and peripheral tissues, they are not found in the bone marrow. These cells are predominantly abundant during the neonatal stage, when the intense lung alveolarization and tissue remodeling occur. RNA sequencing revealed elevated expression of cytokine genes Il13 and Il4, as well as Klrg1, in these cells. They also harbor TCR gene rearrangements, suggesting common developmental pathways with T cells. Furthermore, we demonstrate that neonatal ILC2s play a critical role in macrophage polarization in a naphthalene-induced lung injury model. These findings help explore the differences between pediatric and adult immunity and future therapeutic strategies.

Indexed as

Immunity, InnateLymphocytesThymus GlandAnimalsAnimals, NewbornCD3 ComplexFemaleLectins, C-TypeLungMiceMice, Inbred C57BLMice, TransgenicReceptors, ImmunologicCD3 ComplexKlrg1 protein, mouseLectins, C-TypeReceptors, Immunologicdifferentiationinnate lymphoid cellslungT cellsthymus

Identifiers

PMID42252125
PMCPMC13316946

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.